Year-over-year earnings per share growth for the last twelve months: Precision BioSciences (DTIL)
A bet on elite geneticists and large-scale R&D investments create growth potential, as confirmed by the recorded quarterly EPS growth for Precision BioSciences (DTIL). The value of 85.80 characterizes this level of dynamics. Revenue is generated through technology licensing and royalties from pharma behemoths. The risks of narrow specialization are offset by strategic partnerships with global corporations, ensuring business stability.
Financial and market metric breakdowns for Precision BioSciences Inc. (DTIL)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- company liabilities and liquidity data:
Total Debt to Capital Precision BioSciences|DTIL - Long-Term Debt to Equity|Short-Term Debt to Capital Precision BioSciences|DTIL - Company Total Debt Obligations|Debt to Book Capitalization Ratio Precision BioSciences|DTIL - Long-Term Debt|Company Short-Term Debt Precision BioSciences|Quick Ratio precisionbiosciences.com
- earnings and market multiples details:
DTIL - Net Income|Projected Future Earnings Precision BioSciences|DTIL - Business Payback Period|Forward P/E Multiple Precision BioSciences, Inc.|DTIL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precision BioSciences|DTIL - Operating profit before amortization|Net earnings per share (EPS TTM) Precision BioSciences|DTIL - Net earnings per share for the last 12 months|Quarterly EPS earnings growth precisionbiosciences.com|DTIL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Precision BioSciences
Analysis of all company metrics:Precision BioSciences
The specifics of genome editing at Precision BioSciences (DTIL) and the risks of international cooperation are directly reflected in the quarterly EPS growth rate, which measures net income per share dynamics to eliminate information gaps between reports. The positive trajectory of this metric confirms the business's resilience to geopolitical barriers, while sharp reversals in the trend signal potential capital degradation to investors.
Analysis of competing companies
TEM: Quarterly EPS earnings growth|QGEN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Ionis Pharma|Earnings per share growth in annualized terms for the last twelve months Repligen Inc. RGEN|Year-over-year earnings per share growth for the last twelve months Avidity Biosciences (RNA)|crisprtx.com - Year-over-year earnings per share growth for the last 12 months|GeneDx - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months RARE|Beam Therapeutics Corp - Quarterly EPS earnings growth|SRPT: Year-over-year earnings per share growth for the last twelve months|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia Therapeutics, Inc.|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics Inc STOK|Year-over-year earnings per share growth for the last twelve months BioLife Corp (BLFS)|Year-over-year net earnings per share change for the last twelve months Wave Pharma|Quarterly EPS earnings growth MAZE (Maze Therapeutics Inc)|SION - Year-over-year net earnings per share growth for the last 12 months|Prime Medicine - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Taysha Gene Therapies Inc TSHA|QURE: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months MeiraGTx Corp (MGTX)|Year-over-year earnings per share growth for the last twelve months REGENXBIO Inc.|Year-over-year earnings per share growth for the last 12 months SLDB (solidbio.com)|Quarterly EPS earnings growth OCGN|Year-over-year net earnings per share growth for the last 12 months Pacific Biosciences of California, Inc. PACB|Quarterly EPS earnings growth BNTC (Benitec)|Design Corp (DSGN) - Earnings per share growth in annualized terms for the last twelve months|RCKT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months 4dmoleculartherapeutics.com FDMT|LXEO: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months KRRO|Year-over-year net earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics Corp) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth PRQR|Year-over-year net earnings per share change for the last twelve months codexis.com|Year-over-year earnings per share growth for the last twelve months Sangamo Therapeutics, Inc. SGMO|Nautilus Biotechnology, Inc. - Year-over-year earnings per share growth for the last twelve months|Metagenomi, Inc - Quarterly EPS earnings growth|GBIO (Generation Bio Co.) - Year-over-year earnings per share growth for the last 12 months|Boundless Bio, Inc. (BOLD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months XCUR|IMNN (Imunon Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth RXi Pharmaceuticals|Year-over-year earnings per share growth for the last twelve months Mustang Bio, Inc. (MBIO)|RNAZ: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|Year-over-year earnings per one share growth for the last 12 months APDN|bluebird bio - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ImmunoPrecise Antibodies|OMGA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Singular Genomics Corp|RGLS (Regulus Therapeutics) - Quarterly EPS earnings growth|syros.com (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Telesis Bio (TBIO)|Year-over-year net earnings per share change for the last twelve months TRACON Pharmaceuticals Inc.|Quarterly EPS earnings growth UBX (Unity Bio)
